News Agency
The Times

SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

  • Written by PR Newswire
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
  • SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025, with interim results expected by 2026.
  • Joint R&D project between SK and CEPI includes up to USD 40 million in initial funding support from CEPI.
  • SK bioscience will respond to infectious diseases by expanding the development of...

Read more: SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine...

How Can Businesses Reduce the Risk of Commercial Litigation?

Commercial disputes often begin with a misunderstanding, an unclear contract or a delayed response to a growing problem. Seeking early advice from Litigation Lawyers Sydney with PCL lawyers can help businesses trust and identify legal risks, clarify obligations and create a strategy... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion